An LDL cholesterol level of 160 mg/dL or higher is considered high, and 190 mg/dL or higher is very high. Below 100 mg/dL is optimal. But where your number falls on a chart is only part of the picture. What counts as “too high” for you depends on your other risk factors for heart disease, your age, and whether you already have cardiovascular problems.
LDL Categories by the Numbers
LDL cholesterol is measured in milligrams per deciliter (mg/dL) of blood. The standard breakdown for adults looks like this:
- Optimal: Below 100 mg/dL
- Elevated: 100 to 129 mg/dL
- Borderline high: 130 to 159 mg/dL
- High: 160 to 189 mg/dL
- Very high: 190 mg/dL or above
For children and teens (age 19 or younger), the scale is stricter. A healthy LDL is below 110 mg/dL, and anything above 160 mg/dL with other risk factors, or above 190 mg/dL on its own, may warrant medication if lifestyle changes haven’t brought it down after six months.
Why High LDL Matters for Your Heart
LDL particles carry cholesterol through your bloodstream, and when levels stay elevated, that cholesterol gradually builds up inside artery walls. Over years and decades, those deposits harden into plaques that narrow your arteries and can eventually rupture, triggering a heart attack or stroke.
A large national study that followed over 14,000 adults for more than 20 years quantified this risk. Compared to people with LDL levels of 100 to 129 mg/dL, those with LDL at or above 190 mg/dL had a 63% higher risk of dying from coronary heart disease and a 49% higher risk of dying from cardiovascular disease overall. The relationship between LDL and heart disease risk isn’t a sudden cliff. It’s a gradient: the higher and longer your LDL stays elevated, the more damage accumulates in your arteries.
Your Risk Profile Changes the Target
A person with an LDL of 155 mg/dL and no other risk factors is in a very different situation than someone with the same number who has diabetes or a prior heart attack. Current guidelines from the American Heart Association and American College of Cardiology tie treatment decisions to your estimated 10-year risk of a cardiovascular event, not just your LDL number alone.
If your 10-year risk is low (below 3%) and your LDL is under 160 mg/dL, the recommendation is lifestyle changes: diet, exercise, weight management. Once LDL hits 160 mg/dL or above, even people at low short-term risk may benefit from medication, because the cumulative exposure to high LDL over decades does real damage.
At intermediate risk (5% to 10% over 10 years), statin therapy is recommended regardless of where your LDL sits within the 70 to 189 range. Adults with diabetes between ages 40 and 75 fall into a similar category, with a treatment goal of getting LDL below 100 mg/dL. And if you already have established heart disease, the goal is aggressive: cut LDL by at least 50% from wherever it starts.
When Very High LDL Points to Genetics
An LDL level at or above 190 mg/dL in an adult always deserves close attention, because it raises the possibility of familial hypercholesterolemia (FH), an inherited condition that impairs the body’s ability to clear LDL from the blood. About 1 in 250 people carry the gene variant, and many don’t know it.
The probability of FH is roughly 80% in adults over 30 whose LDL reaches 250 mg/dL or above. For people in their 20s, the threshold is lower: above 220 mg/dL. A family history of early heart attacks (before age 55 in men, 65 in women) makes the diagnosis more likely at any LDL level above 190.
FH matters because these individuals have had sky-high LDL since birth, meaning decades of arterial damage by the time they’re diagnosed. People with severe FH, those with LDL above 310 or 400 mg/dL, often need multiple medications beyond statins to bring levels down to a safe range. If your LDL comes back above 190 and you have any family history of early heart disease, it’s worth asking specifically about FH testing.
How Statins and Other Treatments Lower LDL
Statins remain the first-line treatment. They work by reducing the amount of cholesterol your liver produces, which forces your liver to pull more LDL out of the bloodstream. The intensity of the prescription determines how much your LDL drops:
- Low-intensity statin therapy: reduces LDL by less than 30%
- Moderate-intensity: reduces LDL by 30% to 49%
- High-intensity: reduces LDL by 50% or more
Which intensity you’re prescribed depends on your risk level. Someone at high cardiovascular risk will typically start on high-intensity therapy with the goal of halving their LDL. For primary prevention in lower-risk individuals, moderate intensity is more common. If statins alone don’t reach the target, additional medications can be layered on, particularly for people with very high LDL due to genetic causes, where the goal is to push LDL below 100 mg/dL.
What Lifestyle Changes Can Realistically Do
Diet and exercise can meaningfully lower LDL, but the effects are more modest than many people expect. In a study of healthy young men, a structured moderate-intensity exercise program reduced LDL by about 7%, bringing average levels from roughly 102 mg/dL down to 95 mg/dL. That’s real, but it’s not going to get someone from 190 to 100 on its own.
Dietary changes tend to have a larger impact. Reducing saturated fat, eliminating trans fats, and increasing soluble fiber (found in oats, beans, and certain fruits) can lower LDL by 10% to 15% in many people. Losing excess weight amplifies these effects. Together, a combination of dietary overhaul, regular exercise, and weight loss might reduce LDL by 20% to 30% in someone who makes substantial changes.
For people whose LDL is borderline high, in the 130 to 159 range, and who have no other major risk factors, these lifestyle changes may be enough to bring levels into a safer zone. For anyone starting at 160 or above, lifestyle changes are still important but will likely need to be paired with medication to reach optimal levels. The two approaches complement each other: statins lower the baseline, and healthier habits prevent backsliding and improve other markers like HDL and triglycerides that statins don’t target as effectively.